The Patent Finder

Terms ending in 2039

Juno Therapeutics Inc.

Every in-force patent on Juno Therapeutics Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,535,903Methods and Reagents for Assessing the Presence or Absence of Replication Competent Virus
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 12,264,371Methods and Reagents for Assessing the Presence or Absence of Replication Competent Virus
In force
 · Medium confidence
Juno Therapeutics, Inc.In forceMedium confidence
US 11,413,310Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 11,517,627Cell Surface Conjugates and Related Cell Compositions and Methods
In force
 · High confidence
C3S2 GmbHIn forceHigh confidence
US 11,564,946Methods Associated with Tumor Burden for Assessing Response to a Cell Therapy
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 11,561,219Methods of Enumerating Particles Present in a Cell Composition
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 11,066,475Chimeric Antigen Receptors Specific for B-Cell Maturation Antigen and Encoding Polynucleotides
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 12,428,486Chimeric Antigen Receptors Specific for B-Cell Maturation Antigen and Encoding Polynucleotides
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 12,031,975Methods of Assessing or Monitoring a Response to a Cell Therapy
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 11,896,615Immunotherapy Methods and Compositions Involving Tryptophan Metabolic Pathway Modulators
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
7 more term ends in 2039 · Pro
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
Upgrade to Pro
14 of these are in force and held by Juno Therapeutics Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited